Children with blood cancer have previously been shown to benefit from umbilical cord blood transplants despite HLA mismatch, making it an important alternative for patients who cannot find a matched unrelated donor. However, the limited number of cells in a single cord blood unit obtained from a placenta after the birth of a child has curbed its potential benefits.
http://ift.tt/1tDQ1jE
http://ift.tt/1tDQ1jE
No comments:
Post a Comment